Longitudinal Psychometric Analysis of the Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ) Using Outcomes from the Phase III EXPLORER-HCM Trial.

Reaney, Matthew; Addepalli, Prithvi; Allen, Veleka; Spertus, John A; Dolan, Chantal; Sehnert, Amy J; Fine, Jennifer T

Reaney, Matthew; Addepalli, Prithvi; Allen, Veleka; Spertus, John A; Dolan, Chantal; Sehnert, Amy J; Fine, Jennifer T.

Afiliação

Reaney M; IQVIA, 3 Forbury Place, 23 Forbury Road, Reading, RG1 3JH, UK. matthew.reaney@iqvia.com.
Addepalli P; IQVIA, 3 Forbury Place, 23 Forbury Road, Reading, RG1 3JH, UK.
Allen V; IQVIA, New York, NY, USA.
Spertus JA; Saint Luke's Mid America Heart Institute and the University of Missouri-Kansas City, Kansas City, MO, USA.
Dolan C; CMD Consulting, Sandy, UT, USA.
Sehnert AJ; MyoKardia, Inc., a wholly owned subsidiary of Bristol Myers Squibb, Brisbane, CA, USA.
Fine JT; MyoKardia, Inc., a wholly owned subsidiary of Bristol Myers Squibb, Brisbane, CA, USA.

Pharmacoecon Open ; 6(4): 575-586, 2022 Jul.

Article em En | MEDLINE | ID: mdl-35718845

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Risk_factors_studies Idioma: En Revista: Pharmacoecon Open Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google